
#Medtech #DeepTech #Nantes, spinoff from @CR2TI_Nantes @UnivNantes @Inserm | Enabling a personalized medicine by providing unprecedented tools to clinicians
Nantes, France
Joined March 2021
- Tweets225
- Following49
- Followers31
- Likes90
Last week, our CEO Frédéric Pette proudly received a trophy from @bpifrance, marking BioMAdvanced Diagnostics' selection to join the prestigious Club Excellence.
#Atlanpole #AtlanpoleBiotherapies #LaFrenchCare #medtech
🚀 [Q1 2024 – recap] Our first 3 months of 2024 have already been marked by several key milestones, enabling us to stay confident about our current scheduled roadmap and to prepare for a global launch.
Details : biomadvanced-diagnostics.com…
#MedTech #LaFrenchCare
Why can we reach the market faster than most biotech companies and other medtech ?
1️⃣ THE ABILITY TO ADOPT AN AGILE DEVELOPMENT PROCESS
2️⃣ A MORE STREAMLINED REGULATORY APPROVAL PROCESS
3️⃣ THE USE OF BIO-COLLECTIONS
biomadvanced-diagnostics.com…
#nantes #medtech
Wondering how we're able to process our clinical trials at such a rapid pace?
The secret lies in Bio-collections (or Biobanks). These collections of samples (blood, biopsies, etc.) and clinical data, gathered from patients recruited without bias.
#MedTech
[Milestone] BiomAdvanced Diagnostics is ISO 13485 certified by BSI under certificate number MD 775018.
#ISO13485 #RegulatoryAffairs #MedTech
Crucial to our product : its ease of use and its safety. How do we ensure it ? By conducting specific usability testing (1/5)
📌In pursuit of this objective, two Medical Biology Engineers from a leading French University Hospital biology lab visited our own molecular biology lab. Without prior knowledge of the product, they conducted tests solely relying on the provided instructions for use.
(4/5)
We signed a new licence agreement opening a market of 25 million patients worldwide suffering from cancer or kidney failure and at risk for an irreversible muscular atrophy.
This agreement was an option - 3 additional steps were needed from Clermont Auvergne Innovation for us to confidently move forward.
👏It only took the Clermont teams 6 months to accomplish those 3 steps. This rapid execution and its quality show the teams' remarkable efficiency.
BioMAdvanced Diagnostics has been selected to join the very selective @Bpifrance CLUB EXCELLENCE. 🚀
Among the 200 K companies supported by Bpifrance, only 2,000 companies, including startups, small and med-size companies, and intermediary size companies (ETI), have been chosen
Last week
[Atlanpole Forum] It has become an annual tradition for our CEO, Frederic Pette : attending the @atlanpole Forum. Always invigorating to participate in this event, connect with fellow entrepreneurs, and engage with the entire ecosystem.
#Paysdelaloire #frenchtech
Fundraising, product development key milestones, a licence agreement strengthening our IP, big headways on the regulatory front…A new year always gives the opportunity to reflect on the previous year. Here is a full recap of key milestones & achievements
biomadvanced-diagnostics.com…


























